Miles is Chief Executive Officer of Fecula Biotech Corporation (FBC). In this role, he is responsible for creating, planning, implementing, and integrating the strategic direction of FBC, with the goal of increasing shareholder value.
Previously, Miles was a CEO of Golden Biotechnology Corporation, a listed company in Taiwan. Before that, he was Head of the R&D department at Golden Biotechnology and a research fellow at Academia Sinica in Taiwan. Miles has more than 13 years of drug discovery research experience, which includes preclinical and clinical development of drug candidates. Currently, besides the CEO, Miles also advises on the development of microbiome-related therapeutic drug and functional food at FBC.
Miles graduated with a PhD in Biotechnology from the National Chung Hsing University, and completed his postdoctoral research at Biodiversity Research Center, Genomic Research Center and the Institute of Biological Chemistry in Academia Sinica, Taiwan.